AbbVie Looking to Raise $28 Billion in High-Grade Bond Market
Interactive Video
•
Business
•
University
•
Practice Problem
•
Hard
Wayground Content
FREE Resource
AbbVie plans to raise $28 billion in the bond market to finance its $63 billion acquisition of Allergan. This would be the fourth largest US corporate bond offering. The current market conditions are favorable for such financing, with investment grade bond yields at their narrowest spread since 2018. The bond is rated Triple B, a sector that has grown rapidly and raised some concerns, though it has performed well recently.
Read more
2 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What concerns are raised regarding the Triple B rated tier?
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
When is AbbVie expected to come to the market with their bond offering?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
